Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05108974
PHASE2
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study
Sponsor: Jeff Wozniak
View on ClinicalTrials.gov
Summary
This is a randomized, double-blind controlled trial of choline supplementation in children with Fetal Alcohol Spectrum Disorders (FASD). The study is comparing two administration durations (3 months vs. 6 months) of choline. The primary outcome measures are cognitive measures.
Key Details
Gender
All
Age Range
30 Months - 72 Months
Study Type
INTERVENTIONAL
Enrollment
62
Start Date
2021-10-22
Completion Date
2026-07-31
Last Updated
2025-07-31
Healthy Volunteers
No
Conditions
Interventions
DRUG
Choline Bitartrate
Powdered drink mix for daily consumption
Locations (1)
University of Minnesota
Minneapolis, Minnesota, United States